The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study

Background and Objectives: This study aimed to evaluate whether the addition of hypomethylating agents (HMA) to low-intensity chemotherapy can enhance the clinical efficacy of induction treatment for elderly acute myeloid leukemia (AML) patients who are unsuitable for standard induction therapy. Mat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dan, Wang, Xiaoyu, Tong, Juan, Zhou, Li, Chen, Erling, Zhou, Ziwei, Xue, Lei, Zhang, Xuhan, Sun, Guangyu, Zheng, Changcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865460/
https://www.ncbi.nlm.nih.gov/pubmed/36676738
http://dx.doi.org/10.3390/medicina59010114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865460/
https://www.ncbi.nlm.nih.gov/pubmed/36676738
http://dx.doi.org/10.3390/medicina59010114

Ejemplares similares